Medicare has reached a preliminary decision to cover Biogen's Alzheimer's drug, Aduhelm, for patients who are in approved clinical trials.
Biogen
Biogen announced that new data of their Alzheimer's drug, Aduhelm, shows it can lower levels of a second protein that...
